Form 4 for RNAC Cartesian Therapeutics, Inc.
Accepted 2022-12-07 00:00:00 ET · period of report 2022-12-05 · accession 0001453687-22-000147 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-07 | 2022-12-05 | RNAC | Brunn Carsten | Pres, CEO, Dir | S - Sale | $1.33 | -4,522 | 544.3K | -0.8% | -$6,014 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-05 | S | D | 4,522 | $1.33 | 544,283 | D | — | — |